Korean Hereditary Breast Cancer Study

Korean Breast Cancer Study Group1 site in 1 country2,250 target enrollmentNovember 2007

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Breast Cancer
Sponsor: Korean Breast Cancer Study Group
Enrollment: 2250
Locations: 1
Primary Endpoint: Find out the prevalence of BRCA1/2 mutation of high risk breast cancer patients
Last Updated: 14 years ago

To evaluate the prevalence of BRCA1/2 mutation of breast cancer patients with family history of breast/ovarian cancer.
To evaluate the prevalence of BRCA1/2 mutation of breast cancer patients without family history, but high risk of hereditary cancer.
To evaluate the prevalence of BRCA1/2 mutation of family member of BRCA1/2 mutation.
To evaluate the prevalence of ovarian cancer of population of above 3 groups.

1. To find founder mutation in Korean 2. To correlation prevalence with risk evaluation 3. To find risk factors concerning life style

Registry

clinicaltrials.gov

Start Date

November 2007

End Date

May 2017

Last Updated

14 years ago

Study Type

Observational

Sex

All

Sponsor

Korean Breast Cancer Study Group

•Over 19 years old
•Agree to this study
•Breast cancer patient with family history of breast/ovarian cancer (1 subgroup)
•Breast cancer patient; young age (\<40), bilateral, male, combined ovarian (2 subgroup)
•Family members with 1, 2 subgroups (3 subgroup)